Both in Pharmaceuticals
Capricor Therapeutics vs Crescent Biopharma
Over the past year CAPR returned +47.2% and CBIO returned +11.1%; their daily moves had a correlation of 0.12.
CAPR +47.2% CBIO +11.1%Growth of $1, one year, split-adjusted
| Metric | CAPR | CBIO |
|---|---|---|
| Price | $8.92 | $13.82 |
| Market cap | $518.6M | $513.4M |
| Today | +8.25% | +5.82% |
| 1 month | +15.1% | +1.8% |
| 6 months | −74.1% | −23.5% |
| Year to date | −69.1% | +16.5% |
| 1 year | — | +11.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 43.2× |
| Net cash | $237.9M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 144.1% | 69.7% |
| Short % of float | 48.4% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).